These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 2829002)
1. Limbic regions of the brain of Alzheimer's disease patients show selective changes in mu, delta and kappa opioid receptor binding. Hiller JM; Itzhak Y; Simon EJ NIDA Res Monogr; 1986; 75():559-62. PubMed ID: 2829002 [TBL] [Abstract][Full Text] [Related]
2. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Hiller JM; Itzhak Y; Simon EJ Brain Res; 1987 Mar; 406(1-2):17-23. PubMed ID: 3032356 [TBL] [Abstract][Full Text] [Related]
3. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. Morris BJ; Millan MJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828 [TBL] [Abstract][Full Text] [Related]
4. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain. Schroeder JA; Niculescu M; Unterwald EM Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370 [TBL] [Abstract][Full Text] [Related]
5. Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Mathieu-Kia AM; Fan LQ; Kreek MJ; Simon EJ; Hiller JM Brain Res; 2001 Mar; 893(1-2):121-34. PubMed ID: 11223000 [TBL] [Abstract][Full Text] [Related]
6. Major difference in the expression of delta- and mu-opioid receptors between turtle and rat brain. Xia Y; Haddad GG J Comp Neurol; 2001 Jul; 436(2):202-10. PubMed ID: 11438924 [TBL] [Abstract][Full Text] [Related]
7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Lester PA; Traynor JR Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205 [TBL] [Abstract][Full Text] [Related]
9. Opioid receptor density changes in Alzheimer amygdala and putamen. Barg J; Belcheva M; Rowinski J; Ho A; Burke WJ; Chung HD; Schmidt CA; Coscia CJ Brain Res; 1993 Dec; 632(1-2):209-15. PubMed ID: 8149229 [TBL] [Abstract][Full Text] [Related]
10. Reproductive aging in Japanese quail, Coturnix japonica is associated with changes in central opioid receptors. Ottinger MA; Corbitt C; Hoffman R; Thompson N; Russek-Cohen E; Deviche P Brain Res; 2006 Dec; 1126(1):167-75. PubMed ID: 17045975 [TBL] [Abstract][Full Text] [Related]
11. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. James IF; Goldstein A Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259 [TBL] [Abstract][Full Text] [Related]
12. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
13. Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice. Boutin H; Catherine A; Mackenzie ET; Jauzac P; Dauphin F Acta Neuropathol; 2007 Nov; 114(5):491-500. PubMed ID: 17676326 [TBL] [Abstract][Full Text] [Related]
14. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia. Johansson PA; Andersson M; Andersson KE; Cenci MA Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. Standifer KM; Cheng J; Brooks AI; Honrado CP; Su W; Visconti LM; Biedler JL; Pasternak GW J Pharmacol Exp Ther; 1994 Sep; 270(3):1246-55. PubMed ID: 7932177 [TBL] [Abstract][Full Text] [Related]
16. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat. Richards ML; Sadée W J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482 [TBL] [Abstract][Full Text] [Related]
17. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
18. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Emmerson PJ; Liu MR; Woods JH; Medzihradsky F J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478 [TBL] [Abstract][Full Text] [Related]
19. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists. Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM Receptor; 1994; 4(1):43-53. PubMed ID: 8038706 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration. García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]